Opinion: Realizing the promise of prescription digital therapeutics
Prescription digital therapeutics will be a key piece of the emerging global digital market, which may be worth more than half a trillion dollars by 2025.
by Corey McCann
Oct 29, 2019
3 minutes
Smartphones and tablets have transformed almost every facet of our daily lives, making it nearly impossible to imagine a world without being connected. That same technology has now crossed into health care. Prescription digital therapeutics, or PDTs, are reimagining the way we think about treating disease by using smartphones and tablets to deliver treatment anytime and anywhere.
Prescription digital therapeutics operate at the intersection of biology and technology, with researchers, clinicians, and engineers working in tandem to leverage the power of software to treat disease. They are designed
You’re reading a preview, subscribe to read more.
Start your free 30 days